Advanced Medical Solutions Group (LON:AMS) Given “Buy” Rating at Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of Advanced Medical Solutions Group (LON:AMS) in a research note issued to investors on Wednesday morning, Marketbeat reports. The brokerage currently has a GBX 300 ($3.90) price objective on the stock.

Advanced Medical Solutions Group Price Performance

Advanced Medical Solutions Group stock opened at GBX 203.50 ($2.65) on Wednesday. The stock has a market capitalization of £439.41 million, a P/E ratio of 39.43, a P/E/G ratio of 5.00 and a beta of 0.74. The company’s fifty day moving average price is GBX 211.34 and its 200 day moving average price is GBX 212.81. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. Advanced Medical Solutions Group has a 1 year low of GBX 176.60 ($2.30) and a 1 year high of GBX 275.83 ($3.59).

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.